Clinical Trials · NCT02908087
Incretin-based Therapy in Early Diagnosed Type 1 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University of Oulu
- Enrollment
- 13
- Start date
- Mar 2016
- Locations
- 4 sites, Finland, Sweden
- Primary endpoint
- Serum C-peptide AUC